Principal Financial Group
ACOR

Principal Financial Group’s Acorda Therapeutics ACOR Stock Holding History

Principal Financial Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,455
Closed -$387K – 2381
2020
Q1 		$387K Sell
3,455
-124
-3% -$24.4K ﹤0.01% 1912
2019
Q4 		$876K Buy
3,579
+360
+11% +$90.8K ﹤0.01% 1857
2019
Q3 		$1.11M Buy
3,219
+488
+18% +$265K ﹤0.01% 1814
2019
Q2 		$2.51M Buy
2,731
+25
+0.9% +$30.7K ﹤0.01% 1693
2019
Q1 		$4.32M Sell
2,706
-21
-0.8% -$37.8K ﹤0.01% 1591
2018
Q4 		$5.1M Buy
2,727
+15
+0.6% +$32.6K 0.01% 1500
2018
Q3 		$6.39M Sell
2,712
-401
-13% -$1.24M 0.01% 1526
2018
Q2 		$10.7M Buy
3,113
+47
+2% +$144K 0.01% 1263
2018
Q1 		$8.7M Buy
3,066
+87
+3% +$260K 0.01% 1323
2017
Q4 		$7.67M Buy
2,979
+36
+1% +$102K 0.01% 1397
2017
Q3 		$8.35M Sell
2,943
-26
-0.9% -$68.5K 0.01% 1349
2017
Q2 		$7.02M Buy
2,969
+19
+0.6% +$37.6K 0.01% 1423
2017
Q1 		$7.43M Buy
2,950
+121
+4% +$348K 0.01% 1365
2016
Q4 		$6.38M Buy
2,829
+45
+2% +$107K 0.01% 1431
2016
Q3 		$6.98M Buy
2,784
+80
+3% +$239K 0.01% 1322
2016
Q2 		$8.28M Buy
2,704
+91
+3% +$296K 0.01% 1178
2016
Q1 		$8.29M Buy
2,613
+183
+8% +$760K 0.01% 1113
2015
Q4 		$12.5M Buy
2,430
+182
+8% +$795K 0.02% 821
2015
Q3 		$7.15M Buy
2,248
+12
+0.5% +$46.5K 0.01% 1148
2015
Q2 		$8.95M Sell
2,236
-26
-1% -$100K 0.01% 1069
2015
Q1 		$9.03M Buy
2,262
+80
+4% +$366K 0.01% 1051
2014
Q4 		$10.7M Buy
2,182
+18
+0.8% +$77.2K 0.02% 912
2014
Q3 		$8.8M Sell
2,164
-20
-0.9% -$75K 0.01% 983
2014
Q2 		$8.83M Sell
2,184
-8
-0.4% -$32.6K 0.01% 1014
2014
Q1 		$9.97M Sell
2,192
-265
-11% -$1.07M 0.02% 925
2013
Q4 		$8.61M Buy
2,457
+495
+25% +$1.93M 0.02% 985
2013
Q3 		$8.07M Buy
1,962
+60
+3% +$258K 0.02% 949
2013
Q2 		$7.53M Buy
+1,902
New +$7.83M 0.02% 937

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Principal Financial Group's ACOR Position: Q2 2020 in Review

Principal Financial Group sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 3,455 shares — an estimated $387K sold.

Principal Financial Group first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $12.5M in Q4 2015. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Principal Financial Group reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Principal Financial Group sold 3,455 Acorda Therapeutics shares in Q2 2020, an estimated $387K.
  • Principal Financial Group first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • Principal Financial Group's Acorda Therapeutics position peaked at $12.5M in Q4 2015.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Principal Financial Group's 13F filing for Q2 2020, filed 5 Aug 2020.